News Agency
The Times

ROSEN, National Trial Lawyers, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KRBP

  • Written by Media Outreach
MediaOutReach Newswire logo

New York, New York - Newsfile Corp. - August 22, 2022 - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (i) pursuant and/or traceable to the offering documents issued in connection with the Company's initial public offering conducted on or about July 2, 2021...

Read more: ROSEN, National Trial Lawyers, Encourages Kiromic BioPharma, Inc. Investors to Secure Counsel...

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion